VHL vitasora health limited

Ann: Appendix 3B , page-9

  1. 366 Posts.
    She's only just getting off the ground so next announcements should be timetables regarding clinical trials. They have just appointed a new Managing Director and acquired some new technology to expand their portfolio. VHL will currently be targetting head and neck cancer, non-small cell lung cancer, multiple myeloma,breast cancer and others.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.8¢
Change
0.000(0.00%)
Mkt cap ! $48.11M
Open High Low Value Volume
2.8¢ 2.8¢ 2.8¢ $1.82K 65K

Buyers (Bids)

No. Vol. Price($)
2 513510 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 2403996 2
View Market Depth
Last trade - 10.16am 30/07/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.